Loading…

Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?

Background Self-report questionnaires are widely used to assess changes in quality of life (QoL) during the course of cancer treatment. However, comparing baseline scores to follow-up scores is only justified if patients' internal measurement standards have not changed over time, that is, no re...

Full description

Saved in:
Bibliographic Details
Published in:Acta oncologica 2016-07, Vol.55 (7), p.814-820
Main Authors: Gerlich, Christian, Schuler, Michael, Jelitte, Matthias, Neuderth, Silke, Flentje, Michael, Graefen, Markus, Krüger, Alexander, Mehnert, Anja, Faller, Hermann
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c422t-c39c2c153c8853b639f61f9c6149e8374e54b29b0af0a399f0d40813a22d8acb3
cites cdi_FETCH-LOGICAL-c422t-c39c2c153c8853b639f61f9c6149e8374e54b29b0af0a399f0d40813a22d8acb3
container_end_page 820
container_issue 7
container_start_page 814
container_title Acta oncologica
container_volume 55
creator Gerlich, Christian
Schuler, Michael
Jelitte, Matthias
Neuderth, Silke
Flentje, Michael
Graefen, Markus
Krüger, Alexander
Mehnert, Anja
Faller, Hermann
description Background Self-report questionnaires are widely used to assess changes in quality of life (QoL) during the course of cancer treatment. However, comparing baseline scores to follow-up scores is only justified if patients' internal measurement standards have not changed over time, that is, no response shift occurred. We aimed to examine response shift in terms of reconceptualization, reprioritization and recalibration among prostate cancer patients. Material and methods We included 402 newly diagnosed patients (mean age 65 years) and assessed QoL at the beginning of cancer treatment and three months later. QoL was measured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). We employed structural equation modeling testing measurement invariance between occasions to disentangle 'true' change and change in the measurement model (response shift). Results We found reprioritization effects for both the Physical Functioning and Role Functioning subscales of the EORTC QLQ-C30, indicating that both had gained importance for representing the latent construct of QoL at follow-up. These effects added to the worsening effect evident in the latent construct, thus rendering observed changes even more pronounced. In addition, we found recalibration effects for both the Emotional Functioning and Cognitive Functioning subscales indicating judgments becoming more lenient over time. These effects counteracted 'true' negative changes thus obscuring any substantial changes on the observed level. Conclusion Our results suggest that changes observed in some subscales of the EORTC QLQ-C30 should not be taken at face value as they may be affected by patients' changed measurement standards.
doi_str_mv 10.3109/0284186x.2015.1136749
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1795876481</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1795876481</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-c39c2c153c8853b639f61f9c6149e8374e54b29b0af0a399f0d40813a22d8acb3</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhC0EoqXwE0C-lUuKH4ljc0Go4iVVgkOReoscd01TpUmwHYme-OskNHDalWZmV_MhdEnJjFOibgiTMZXia8YITWaUcpHG6giNqUhoxJhYHaNx74k602qEzrzfEkIYT5NTNGJCSkaUGKPvN1f7oANgoysDDjc6FFAFP8WfrS6LsMe1xWVhAWvvwftdL2JtupjHYQO4ccVOuz0ODnTo1W7TWzChdvtbPF26FqbYbHT1Abh22IFv6soD9pvChrtzdGJ16eFimBP0_viwnD9Hi9enl_n9IjIxYyEyXBlmaMKNlAnPBVdWUKuMoLECydMYkjhnKifaEs2VsmQdE0m5Zmwttcn5BF0f7jau_mzBh2xXeANlqSuoW5_RVCUyFXGXmaDkYP3t6MBmQ8WMkqxnnw3sV1nPPhvYd7mr4UWb72D9n_qDzX8A8zWBkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1795876481</pqid></control><display><type>article</type><title>Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Gerlich, Christian ; Schuler, Michael ; Jelitte, Matthias ; Neuderth, Silke ; Flentje, Michael ; Graefen, Markus ; Krüger, Alexander ; Mehnert, Anja ; Faller, Hermann</creator><creatorcontrib>Gerlich, Christian ; Schuler, Michael ; Jelitte, Matthias ; Neuderth, Silke ; Flentje, Michael ; Graefen, Markus ; Krüger, Alexander ; Mehnert, Anja ; Faller, Hermann</creatorcontrib><description>Background Self-report questionnaires are widely used to assess changes in quality of life (QoL) during the course of cancer treatment. However, comparing baseline scores to follow-up scores is only justified if patients' internal measurement standards have not changed over time, that is, no response shift occurred. We aimed to examine response shift in terms of reconceptualization, reprioritization and recalibration among prostate cancer patients. Material and methods We included 402 newly diagnosed patients (mean age 65 years) and assessed QoL at the beginning of cancer treatment and three months later. QoL was measured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). We employed structural equation modeling testing measurement invariance between occasions to disentangle 'true' change and change in the measurement model (response shift). Results We found reprioritization effects for both the Physical Functioning and Role Functioning subscales of the EORTC QLQ-C30, indicating that both had gained importance for representing the latent construct of QoL at follow-up. These effects added to the worsening effect evident in the latent construct, thus rendering observed changes even more pronounced. In addition, we found recalibration effects for both the Emotional Functioning and Cognitive Functioning subscales indicating judgments becoming more lenient over time. These effects counteracted 'true' negative changes thus obscuring any substantial changes on the observed level. Conclusion Our results suggest that changes observed in some subscales of the EORTC QLQ-C30 should not be taken at face value as they may be affected by patients' changed measurement standards.</description><identifier>ISSN: 0284-186X</identifier><identifier>EISSN: 1651-226X</identifier><identifier>DOI: 10.3109/0284186x.2015.1136749</identifier><identifier>PMID: 26882096</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Cognition ; Emotions ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Models, Biological ; Prostatic Neoplasms - psychology ; Prostatic Neoplasms - therapy ; Quality of Life ; Self Report ; Socioeconomic Factors ; Surveys and Questionnaires</subject><ispartof>Acta oncologica, 2016-07, Vol.55 (7), p.814-820</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-c39c2c153c8853b639f61f9c6149e8374e54b29b0af0a399f0d40813a22d8acb3</citedby><cites>FETCH-LOGICAL-c422t-c39c2c153c8853b639f61f9c6149e8374e54b29b0af0a399f0d40813a22d8acb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26882096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerlich, Christian</creatorcontrib><creatorcontrib>Schuler, Michael</creatorcontrib><creatorcontrib>Jelitte, Matthias</creatorcontrib><creatorcontrib>Neuderth, Silke</creatorcontrib><creatorcontrib>Flentje, Michael</creatorcontrib><creatorcontrib>Graefen, Markus</creatorcontrib><creatorcontrib>Krüger, Alexander</creatorcontrib><creatorcontrib>Mehnert, Anja</creatorcontrib><creatorcontrib>Faller, Hermann</creatorcontrib><title>Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?</title><title>Acta oncologica</title><addtitle>Acta Oncol</addtitle><description>Background Self-report questionnaires are widely used to assess changes in quality of life (QoL) during the course of cancer treatment. However, comparing baseline scores to follow-up scores is only justified if patients' internal measurement standards have not changed over time, that is, no response shift occurred. We aimed to examine response shift in terms of reconceptualization, reprioritization and recalibration among prostate cancer patients. Material and methods We included 402 newly diagnosed patients (mean age 65 years) and assessed QoL at the beginning of cancer treatment and three months later. QoL was measured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). We employed structural equation modeling testing measurement invariance between occasions to disentangle 'true' change and change in the measurement model (response shift). Results We found reprioritization effects for both the Physical Functioning and Role Functioning subscales of the EORTC QLQ-C30, indicating that both had gained importance for representing the latent construct of QoL at follow-up. These effects added to the worsening effect evident in the latent construct, thus rendering observed changes even more pronounced. In addition, we found recalibration effects for both the Emotional Functioning and Cognitive Functioning subscales indicating judgments becoming more lenient over time. These effects counteracted 'true' negative changes thus obscuring any substantial changes on the observed level. Conclusion Our results suggest that changes observed in some subscales of the EORTC QLQ-C30 should not be taken at face value as they may be affected by patients' changed measurement standards.</description><subject>Aged</subject><subject>Cognition</subject><subject>Emotions</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Prostatic Neoplasms - psychology</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Quality of Life</subject><subject>Self Report</subject><subject>Socioeconomic Factors</subject><subject>Surveys and Questionnaires</subject><issn>0284-186X</issn><issn>1651-226X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNo9kEtPwzAQhC0EoqXwE0C-lUuKH4ljc0Go4iVVgkOReoscd01TpUmwHYme-OskNHDalWZmV_MhdEnJjFOibgiTMZXia8YITWaUcpHG6giNqUhoxJhYHaNx74k602qEzrzfEkIYT5NTNGJCSkaUGKPvN1f7oANgoysDDjc6FFAFP8WfrS6LsMe1xWVhAWvvwftdL2JtupjHYQO4ccVOuz0ODnTo1W7TWzChdvtbPF26FqbYbHT1Abh22IFv6soD9pvChrtzdGJ16eFimBP0_viwnD9Hi9enl_n9IjIxYyEyXBlmaMKNlAnPBVdWUKuMoLECydMYkjhnKifaEs2VsmQdE0m5Zmwttcn5BF0f7jau_mzBh2xXeANlqSuoW5_RVCUyFXGXmaDkYP3t6MBmQ8WMkqxnnw3sV1nPPhvYd7mr4UWb72D9n_qDzX8A8zWBkQ</recordid><startdate>20160702</startdate><enddate>20160702</enddate><creator>Gerlich, Christian</creator><creator>Schuler, Michael</creator><creator>Jelitte, Matthias</creator><creator>Neuderth, Silke</creator><creator>Flentje, Michael</creator><creator>Graefen, Markus</creator><creator>Krüger, Alexander</creator><creator>Mehnert, Anja</creator><creator>Faller, Hermann</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160702</creationdate><title>Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?</title><author>Gerlich, Christian ; Schuler, Michael ; Jelitte, Matthias ; Neuderth, Silke ; Flentje, Michael ; Graefen, Markus ; Krüger, Alexander ; Mehnert, Anja ; Faller, Hermann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-c39c2c153c8853b639f61f9c6149e8374e54b29b0af0a399f0d40813a22d8acb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Cognition</topic><topic>Emotions</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Prostatic Neoplasms - psychology</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Quality of Life</topic><topic>Self Report</topic><topic>Socioeconomic Factors</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerlich, Christian</creatorcontrib><creatorcontrib>Schuler, Michael</creatorcontrib><creatorcontrib>Jelitte, Matthias</creatorcontrib><creatorcontrib>Neuderth, Silke</creatorcontrib><creatorcontrib>Flentje, Michael</creatorcontrib><creatorcontrib>Graefen, Markus</creatorcontrib><creatorcontrib>Krüger, Alexander</creatorcontrib><creatorcontrib>Mehnert, Anja</creatorcontrib><creatorcontrib>Faller, Hermann</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta oncologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerlich, Christian</au><au>Schuler, Michael</au><au>Jelitte, Matthias</au><au>Neuderth, Silke</au><au>Flentje, Michael</au><au>Graefen, Markus</au><au>Krüger, Alexander</au><au>Mehnert, Anja</au><au>Faller, Hermann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?</atitle><jtitle>Acta oncologica</jtitle><addtitle>Acta Oncol</addtitle><date>2016-07-02</date><risdate>2016</risdate><volume>55</volume><issue>7</issue><spage>814</spage><epage>820</epage><pages>814-820</pages><issn>0284-186X</issn><eissn>1651-226X</eissn><abstract>Background Self-report questionnaires are widely used to assess changes in quality of life (QoL) during the course of cancer treatment. However, comparing baseline scores to follow-up scores is only justified if patients' internal measurement standards have not changed over time, that is, no response shift occurred. We aimed to examine response shift in terms of reconceptualization, reprioritization and recalibration among prostate cancer patients. Material and methods We included 402 newly diagnosed patients (mean age 65 years) and assessed QoL at the beginning of cancer treatment and three months later. QoL was measured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). We employed structural equation modeling testing measurement invariance between occasions to disentangle 'true' change and change in the measurement model (response shift). Results We found reprioritization effects for both the Physical Functioning and Role Functioning subscales of the EORTC QLQ-C30, indicating that both had gained importance for representing the latent construct of QoL at follow-up. These effects added to the worsening effect evident in the latent construct, thus rendering observed changes even more pronounced. In addition, we found recalibration effects for both the Emotional Functioning and Cognitive Functioning subscales indicating judgments becoming more lenient over time. These effects counteracted 'true' negative changes thus obscuring any substantial changes on the observed level. Conclusion Our results suggest that changes observed in some subscales of the EORTC QLQ-C30 should not be taken at face value as they may be affected by patients' changed measurement standards.</abstract><cop>England</cop><pmid>26882096</pmid><doi>10.3109/0284186x.2015.1136749</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0284-186X
ispartof Acta oncologica, 2016-07, Vol.55 (7), p.814-820
issn 0284-186X
1651-226X
language eng
recordid cdi_proquest_miscellaneous_1795876481
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Aged
Cognition
Emotions
Follow-Up Studies
Humans
Male
Middle Aged
Models, Biological
Prostatic Neoplasms - psychology
Prostatic Neoplasms - therapy
Quality of Life
Self Report
Socioeconomic Factors
Surveys and Questionnaires
title Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A28%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostate%20cancer%20patients'%20quality%20of%20life%20assessments%20across%20the%20primary%20treatment%20trajectory:%20'True'%20change%20or%20response%20shift?&rft.jtitle=Acta%20oncologica&rft.au=Gerlich,%20Christian&rft.date=2016-07-02&rft.volume=55&rft.issue=7&rft.spage=814&rft.epage=820&rft.pages=814-820&rft.issn=0284-186X&rft.eissn=1651-226X&rft_id=info:doi/10.3109/0284186x.2015.1136749&rft_dat=%3Cproquest_cross%3E1795876481%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-c39c2c153c8853b639f61f9c6149e8374e54b29b0af0a399f0d40813a22d8acb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1795876481&rft_id=info:pmid/26882096&rfr_iscdi=true